BNP Paribas Asset Management
EBS icon

BNP Paribas Asset Management’s Emergent Biosolutions EBS Stock Holding History

BNP Paribas Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-163,497
Closed -$2.36M – 810
2013
Q2 		$2.36M Buy
+163,497
New +$2.37M 0.02% 571

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

BNP Paribas Asset Management's EBS Position: Q3 2013 in Review

BNP Paribas Asset Management sold out of Emergent Biosolutions (EBS) in Q3 2013, closing a stake of 163,497 shares — an estimated $2.36M sold.

BNP Paribas Asset Management first reported a position in EBS in Q2 2013 and held it in 1 quarter. The position peaked at $2.36M in Q2 2013. 126 funds tracked by Wall St. Rank hold EBS as of Q3 2013.

  • BNP Paribas Asset Management reported no remaining Emergent Biosolutions position as of Q3 2013 after selling out during the quarter.
  • BNP Paribas Asset Management sold 163,497 Emergent Biosolutions shares in Q3 2013, an estimated $2.36M.
  • BNP Paribas Asset Management first reported a position in Emergent Biosolutions in Q2 2013 and held it in 1 quarter.
  • BNP Paribas Asset Management's Emergent Biosolutions position peaked at $2.36M in Q2 2013.
  • 126 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2013.

Based on BNP Paribas Asset Management's 13F filing for Q3 2013, filed 13 Nov 2013.